PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.
top of page
Recent Posts
See AllPneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced that it received Phase I SBIR grants from the NSF. The awards w
120
PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development Corporation of Maryland about their technology and its ability to increa
70
PneumoNIX Medical is 1 of 50 startups nationwide selected to present to the nations top angel investors. The showcase features the most promising startups from life science and technology companies. R
40
bottom of page